PHARMACEUTICAL COMPOSITION OF GLUTATHIONE MODULATORS WITH ANTIMONY AND/OR ARSENIC FOR CANCER THERAPY

摘要

The present invention relates to combination of glutathione modulators with antimony and/or arsenic for cancer therapy. More particularly, the present invention relates to a pharmaceutical composition for the treatment of cancer, which comprises a therapeutical amount of a glutathione (GSH) modulator with antimony and/or arsenic in association with a pharmaceutically acceptable carrier.